- About Overview
- Diversity, Equity, and Inclusion
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
DeGrado receives Protein Society’s Stein and Moore Award
By David Jacobson / Wed Feb 11, 2015
The award is given annually by the international society “to recognize eminent leaders in protein science who have made sustained high-impact research contributions to the field.”
His impact on the field of protein science can hardly be overestimated.
—The Protein Society
In announcing the award, which will be conferred at the society’s annual symposium in July in Barcelona, Spain, the organization noted: “DeGrado’s bold body of work spanning decades has taught us that proteins can be rationally designed in a staged modular manner based on simple chemical and conformational principles…
“His pioneering work has shown that simple chemical principles can be rationally applied to highly complex systems to both understand them and create new materials and potential therapeutics. His impact on the field of protein science can hardly be overestimated.”
DeGrado began his career with DuPont Central Research, rising to senior director at DuPont Merck Pharmaceutical Co, before becoming a professor of biochemistry and biophysics at the University of Pennsylvania School of Medicine. He joined the UCSF School of Pharmacy faculty in 2011.
More about Degrado’s work in protein engineering
William DeGrado’s research has advanced the rational engineering of protein molecules—the gene-generated chains of amino acids that fold into complex three-dimensional shapes to carry out the activities of life in our cells.
DeGrado has pioneered in designing protein molecules from scratch (de novo design), molecules that can fold into functional structures both in solution and spanning cell membranes. His work applies fundamental biophysical principles translated into computational algorithms to select amino acid sequences. These sequences then fold into structures to achieve specific chemical and biological properties, such as catalysis, ligand/co-factor binding, and the transport of other molecules and ions across membranes.
Such designed proteins allow scientists to experimentally analyze how proteins fold, how structure generates function, and whether their knowledge is sufficiently accurate and advanced to synthesize versions that closely mimic nature. These engineered molecules could also potentially be used to treat disease.
School of Pharmacy, Department of Pharmaceutical Chemistry, PharmD Degree Program, Chemistry and Chemical Biology Graduate Program (CCB), Biophysics Graduate Program (BP), CCB, Biophysics
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.